EOLS – Evolus, Inc.
EOLS
$10.69Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $679,742,848.00
EPSttm : -0.81
Evolus, Inc. Common Stock
$10.69
Float Short %
12.57
Margin Of Safety %
Put/Call OI Ratio
0.2
EPS Next Q Diff
-0.12
EPS Last/This Y
0.75
EPS This/Next Y
0.76
Price
10.7
Target Price
24
Analyst Recom
1
Performance Q
-3.78
Relative Volume
1.85
Beta
1.12
Ticker: EOLS
22 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-03-06 | EOLS | 13.51 | 0.06 | 0.02 | 4092 |
2025-03-07 | EOLS | 13.57 | 0.06 | 5.00 | 4078 |
2025-03-10 | EOLS | 12.71 | 0.06 | 1.14 | 4078 |
2025-03-11 | EOLS | 12.71 | 0.06 | 0.15 | 4074 |
2025-03-12 | EOLS | 13.43 | 0.06 | 1.36 | 4083 |
2025-03-13 | EOLS | 12.98 | 0.06 | 1.10 | 4097 |
2025-03-14 | EOLS | 13.2 | 0.07 | 0.06 | 4108 |
2025-03-17 | EOLS | 13.59 | 0.07 | 0.08 | 4097 |
2025-03-18 | EOLS | 13.29 | 0.07 | 0.46 | 4094 |
2025-03-19 | EOLS | 13.49 | 0.07 | 0.53 | 4107 |
2025-03-20 | EOLS | 13.28 | 0.06 | 0.60 | 4082 |
2025-03-21 | EOLS | 13.03 | 0.06 | 999.99 | 4075 |
2025-03-24 | EOLS | 12.98 | 0.06 | 0.83 | 3583 |
2025-03-25 | EOLS | 12.43 | 0.08 | 0.26 | 3740 |
2025-03-26 | EOLS | 12.41 | 0.08 | 0.16 | 3836 |
2025-03-27 | EOLS | 12.24 | 0.08 | 1.43 | 3930 |
2025-03-28 | EOLS | 12.04 | 0.09 | 25.65 | 3969 |
2025-03-31 | EOLS | 12.03 | 0.21 | 0.53 | 4395 |
2025-04-01 | EOLS | 12.05 | 0.21 | 0.00 | 4408 |
2025-04-02 | EOLS | 12.22 | 0.21 | 0.00 | 4459 |
2025-04-03 | EOLS | 11.39 | 0.21 | 0.00 | 4464 |
2025-04-04 | EOLS | 10.69 | 0.20 | 999.99 | 4513 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-03-06 | EOLS | 13.52 | 115.4 | 36.0 | -0.28 |
2025-03-07 | EOLS | 13.55 | 44.4 | 12.8 | -0.07 |
2025-03-10 | EOLS | 12.73 | 8.6 | 14.0 | -0.01 |
2025-03-11 | EOLS | 12.72 | 8.6 | 12.8 | -0.01 |
2025-03-12 | EOLS | 13.43 | 8.6 | 11.9 | -0.01 |
2025-03-13 | EOLS | 12.96 | 8.6 | 13.5 | -0.01 |
2025-03-14 | EOLS | 13.20 | 8.6 | 12.6 | -0.01 |
2025-03-17 | EOLS | 13.59 | 8.6 | 12.4 | -0.01 |
2025-03-18 | EOLS | 13.26 | 8.6 | 13.3 | -0.01 |
2025-03-19 | EOLS | 13.47 | 8.6 | 12.6 | -0.01 |
2025-03-20 | EOLS | 13.25 | 8.6 | 13.2 | -0.01 |
2025-03-21 | EOLS | 13.01 | 8.6 | 13.2 | -0.01 |
2025-03-24 | EOLS | 13.00 | 8.6 | 12.9 | -0.01 |
2025-03-25 | EOLS | 12.43 | 8.6 | 13.6 | -0.01 |
2025-03-26 | EOLS | 12.43 | 8.6 | 12.9 | -0.01 |
2025-03-27 | EOLS | 12.24 | 8.6 | 13.2 | -0.01 |
2025-03-28 | EOLS | 12.05 | -9.4 | 13.2 | -0.06 |
2025-03-31 | EOLS | 12.02 | -9.4 | 12.9 | -0.06 |
2025-04-01 | EOLS | 11.99 | -9.4 | 13.0 | -0.06 |
2025-04-02 | EOLS | 12.22 | -9.4 | 12.6 | -0.06 |
2025-04-03 | EOLS | 11.39 | -9.4 | 14.0 | -0.06 |
2025-04-04 | EOLS | 10.70 | -9.4 | 13.9 | -0.06 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-03-06 | EOLS | -0.24 | 3.64 | 11.72 |
2025-03-07 | EOLS | -0.19 | 3.64 | 11.68 |
2025-03-10 | EOLS | -0.19 | 3.60 | 11.68 |
2025-03-11 | EOLS | -0.19 | 3.60 | 11.68 |
2025-03-12 | EOLS | -0.19 | 3.60 | 12.12 |
2025-03-13 | EOLS | -0.19 | 3.60 | 12.12 |
2025-03-14 | EOLS | -0.19 | 3.60 | 12.12 |
2025-03-17 | EOLS | -0.37 | 3.61 | 12.12 |
2025-03-18 | EOLS | -0.35 | 3.61 | 12.17 |
2025-03-19 | EOLS | -0.35 | 3.61 | 12.17 |
2025-03-20 | EOLS | -0.35 | 3.61 | 12.17 |
2025-03-21 | EOLS | -2.20 | 3.61 | 12.16 |
2025-03-24 | EOLS | -2.20 | 3.61 | 12.16 |
2025-03-25 | EOLS | -2.25 | 3.61 | 12.13 |
2025-03-26 | EOLS | -2.25 | 3.61 | 12.57 |
2025-03-27 | EOLS | -2.25 | 3.61 | 12.57 |
2025-03-28 | EOLS | -2.25 | 3.61 | 12.57 |
2025-03-31 | EOLS | -2.33 | 3.62 | 12.57 |
2025-04-01 | EOLS | -2.33 | 3.62 | 12.57 |
2025-04-02 | EOLS | -2.33 | 3.62 | 12.57 |
2025-04-03 | EOLS | -2.33 | 3.62 | 12.57 |
2025-04-04 | EOLS | -2.33 | 3.62 | 12.57 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.04
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
-2.33
Institutional Transactions
3.62
Beta
1.12
Average Sales Estimate Current Quarter
73
Average Sales Estimate Next Quarter
82
Fair Value
Quality Score
40
Growth Score
55
Sentiment Score
37
Actual DrawDown %
40
Max Drawdown 5-Year %
-68.4
Target Price
24
P/E
Forward P/E
16.11
PEG
P/S
2.55
P/B
122.93
P/Free Cash Flow
EPS
-0.81
Average EPS Est. Cur. Y
-0.06
EPS Next Y. (Est.)
0.7
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-18.94
Relative Volume
1.85
Return on Equity vs Sector %
-932.9
Return on Equity vs Industry %
-921.1
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.06
EBIT Estimation
13.9
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 332
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading